BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 16477629)

  • 41. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M; Schwabe W; Sander S; Kron M; Sträter J; Polat S; Kettner E; Weiser HF; Baumann W; Schramm H; Häusler P; Ott K; Behnke D; Staib L; Beger HG; Link KH
    Clin Cancer Res; 2003 Sep; 9(11):4116-24. PubMed ID: 14519634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential effects of two fluorouracil administration regimens for colorectal cancer.
    Matsusaka S; Yamasaki H; Kitayama Y; Okada T; Maeda S
    Oncol Rep; 2003; 10(1):109-13. PubMed ID: 12469154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Profiling of fluorouracil-related genes by microdissection technique in hepatocellular carcinoma.
    Takahashi T; Yoshida H; Mamada Y; Taniai N; Mizuguchi Y; Shimizu T; Kakinuma D; Ishikawa Y; Akimaru K; Sugisaki Y; Tajiri T
    Hepatogastroenterology; 2007 Sep; 54(78):1612-6. PubMed ID: 18019677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thymidilate synthase expression predicts longer survival in patients with stage II colon cancer treated with 5-flurouracil independently of microsatellite instability.
    Donada M; Bonin S; Nardon E; De Pellegrin A; Decorti G; Stanta G
    J Cancer Res Clin Oncol; 2011 Feb; 137(2):201-10. PubMed ID: 20387074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy.
    Tanaka K; Saigusa S; Toiyama Y; Koike Y; Okugawa Y; Yokoe T; Inoue Y; Kobayashi M; Miki C; Kusunoki M
    J Surg Oncol; 2012 May; 105(6):529-34. PubMed ID: 22006578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy.
    Libra M; Navolanic PM; Talamini R; Cecchin E; Sartor F; Tumolo S; Masier S; Travali S; Boiocchi M; Toffoli G
    BMC Cancer; 2004 Mar; 4():11. PubMed ID: 15040806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thymidine phosphorylase mRNA level predicts survival of patients with advanced oropharyngeal cancer.
    Ijuin T; Nibu K; Doi K; Inoue H; Saitoh M; Ohtsuki N; Makino K; Amatsu M
    Acta Otolaryngol; 2007 Mar; 127(3):305-11. PubMed ID: 17364369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer.
    Jeung HC; Rha SY; Shin SJ; Lim SJ; Roh JK; Noh SH; Chung HC
    Anticancer Drugs; 2011 Sep; 22(8):801-10. PubMed ID: 21572321
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression level of thymidylate synthase is a good predictor of chemosensitivity to 5-fluorouracil in colorectal cancer.
    Inoue T; Hibi K; Nakayama G; Komatsu Y; Fukuoka T; Kodera Y; Ito K; Akiyama S; Nakao A
    J Gastroenterol; 2005 Feb; 40(2):143-7. PubMed ID: 15770397
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Expression of metabolic enzymes of fluoropyrimidines in primary colorectal cancer and its clinical significance].
    Wang H; Dong PD; Zhang LH; Ji JF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Jun; 37(3):269-72. PubMed ID: 15968317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression after administration of 5-fluorouracil to patients with colorectal cancer.
    Mauritz R; van Groeningen CJ; Smid K; Jansen G; Pinedo HM; Peters GJ
    Int J Cancer; 2007 Jun; 120(12):2609-12. PubMed ID: 17330233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Orotate phosphoribosyltransferase expression level in tumors is a potential determinant of the efficacy of 5-fluorouracil.
    Sakamoto E; Nagase H; Kobunai T; Oie S; Oka T; Fukushima M; Oka T
    Biochem Biophys Res Commun; 2007 Nov; 363(1):216-22. PubMed ID: 17854773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlations of clinicopathological factors with protein expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in colorectal cancer.
    Sumi T; Katsumata K; Tsuchida A; Ishizaki T; Shimazu M; Aoki T
    Chemotherapy; 2010; 56(2):120-6. PubMed ID: 20407238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of thymidylate synthase, orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in thymic epithelial tumors.
    Kaira K; Serizawa M; Koh Y; Miura S; Kaira R; Abe M; Nakagawa K; Ohde Y; Okumura T; Murakami H; Tsuya A; Nakamura Y; Naito T; Takahashi T; Kondo H; Nakajima T; Endo M; Yamamoto N
    Lung Cancer; 2011 Dec; 74(3):419-25. PubMed ID: 21550686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer.
    Kamoshida S; Shiogama K; Shimomura R; Inada K; Sakurai Y; Ochiai M; Matuoka H; Maeda K; Tsutsumi Y
    Oncol Rep; 2005 Nov; 14(5):1223-30. PubMed ID: 16211289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in thymoma.
    Sasaki H; Fukai I; Kiriyama M; Kaji M; Yano M; Yamakawa Y; Fujii Y
    Surg Today; 2003; 33(2):83-8. PubMed ID: 12616366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene expression of 5-fluorouracil metabolic enzymes in primary gastric cancer: correlation with drug sensitivity against 5-fluorouracil.
    Kodera Y; Ito S; Fujiwara M; Mochizuki Y; Nakayama G; Ohashi N; Koike M; Yamamura Y; Nakao A
    Cancer Lett; 2007 Jul; 252(2):307-13. PubMed ID: 17303323
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.
    Johnston PG; Lenz HJ; Leichman CG; Danenberg KD; Allegra CJ; Danenberg PV; Leichman L
    Cancer Res; 1995 Apr; 55(7):1407-12. PubMed ID: 7882343
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53 and p21 in metastatic liver tumor from colorectal cancer after 5-fluorouracil-based chemotherapy.
    Yamagishi S; Shimada H; Ishikawa T; Fujii S; Tanaka K; Masui H; Yamaguchi S; Ichikawa Y; Togo S; Ike H
    Anticancer Res; 2005; 25(2B):1237-42. PubMed ID: 15865071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dihydropyrimidine dehydrogenase activity and mRNA expression in advanced gastric cancer analyzed in relation to effectiveness of preoperative 5-fluorouracil-based chemotherapy.
    Takabayashi A; Iwata S; Kawai Y; Kanai M; Taki Y; Takechi T; Fukushima M
    Int J Oncol; 2000 Nov; 17(5):889-95. PubMed ID: 11029488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.